Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Tokyo - Delayed Quote JPY

CE Holdings Co.,Ltd. (4320.T)

646.00
+2.00
+(0.31%)
As of 9:51:45 AM GMT+9. Market Open.
Loading Chart for 4320.T
  • Previous Close 644.00
  • Open 647.00
  • Bid 645.00 x --
  • Ask 648.00 x --
  • Day's Range 645.00 - 651.00
  • 52 Week Range 355.00 - 697.00
  • Volume 14,100
  • Avg. Volume 94,151
  • Market Cap (intraday) 9.813B
  • Beta (5Y Monthly) 0.45
  • PE Ratio (TTM) 78.97
  • EPS (TTM) 8.18
  • Earnings Date May 9, 2025
  • Forward Dividend & Yield 40.00 (6.21%)
  • Ex-Dividend Date Sep 29, 2025
  • 1y Target Est --

CE Holdings Co.,Ltd., through its subsidiaries, develops and sells electronic medical record systems and medical information systems in Japan. The company develops MI RA Is, an electronic medical record system and consignment system; develops, implements, operates, and maintains nursing work systems; offers clinical development support services using imaging technology; and dispatches skilled human resources for clinical development. It also provides industrial health, human resource, and marketing services; and offers digital marketing implementation support and digital marketing human resource development services. The company was formerly known as CEI Corporation and changed its name to CE Holdings Co., Ltd. in April 2013. CE Holdings Co.,Ltd. was incorporated in 1996 and is headquartered in Sapporo, Japan.

www.ce-hd.co.jp

606

Full Time Employees

September 30

Fiscal Year Ends

Recent News: 4320.T

View More

Performance Overview: 4320.T

Trailing total returns as of 4/22/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

4320.T
17.03%
Nikkei 225 (^N225)
14.41%

1-Year Return

4320.T
7.85%
Nikkei 225 (^N225)
8.79%

3-Year Return

4320.T
44.03%
Nikkei 225 (^N225)
25.98%

5-Year Return

4320.T
57.40%
Nikkei 225 (^N225)
78.43%

Compare To: 4320.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4320.T

View More

Valuation Measures

Annual
As of 4/21/2025
  • Market Cap

    9.74B

  • Enterprise Value

    8.08B

  • Trailing P/E

    78.63

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.67

  • Price/Book (mrq)

    1.60

  • Enterprise Value/Revenue

    0.55

  • Enterprise Value/EBITDA

    5.67

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.83%

  • Return on Assets (ttm)

    7.93%

  • Return on Equity (ttm)

    5.82%

  • Revenue (ttm)

    15.18B

  • Net Income Avi to Common (ttm)

    278M

  • Diluted EPS (ttm)

    8.18

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.49B

  • Total Debt/Equity (mrq)

    31.10%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 4320.T

View More

Company Insights: 4320.T

Research Reports: 4320.T

View More

People Also Watch